During acquired resistance to BRAF inhibition, the high expression of AXL, a member of TAM, is a marker of melanoma dedifferentiation, indicating these are vulnerable to ferroptosis inducers (Tsoi et al., 2018). This evidence concerns the gene AXL and melanoma.